These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Beta-catenin and cell proliferation in normal and transformed intestinal cells]. Hamelin R; Duval A Med Sci (Paris); 2003; 19(8-9):788-90. PubMed ID: 14593607 [No Abstract] [Full Text] [Related]
26. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation. Spychala J; Kitajewski J Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841 [TBL] [Abstract][Full Text] [Related]
27. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development. Schmidt M; Patterson M; Farrell E; Münsterberg A Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726 [TBL] [Abstract][Full Text] [Related]
29. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling. Park CH; Hahm ER; Park S; Kim HK; Yang CH FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313 [TBL] [Abstract][Full Text] [Related]
30. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377 [TBL] [Abstract][Full Text] [Related]
31. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505 [TBL] [Abstract][Full Text] [Related]
32. Transactivation of vimentin by beta-catenin in human breast cancer cells. Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294 [TBL] [Abstract][Full Text] [Related]
33. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation. Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616 [TBL] [Abstract][Full Text] [Related]
34. Decisions, decisions: beta-catenin chooses between adhesion and transcription. Harris TJ; Peifer M Trends Cell Biol; 2005 May; 15(5):234-7. PubMed ID: 15866026 [TBL] [Abstract][Full Text] [Related]
35. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893 [TBL] [Abstract][Full Text] [Related]
36. The role of beta-catenin signaling in the malignant potential of cystitis glandularis. Bryan RT; Nicholls JH; Harrison RF; Jankowski JA; Wallace DM J Urol; 2003 Nov; 170(5):1892-6. PubMed ID: 14532801 [TBL] [Abstract][Full Text] [Related]
37. The 9 lives of beta-catenin. Mittal K Hum Pathol; 2004 Jun; 35(6):647-8. PubMed ID: 15188129 [No Abstract] [Full Text] [Related]
38. [Growth, differentiation, and regeneration of liver and skin]. Tateno C; Yoshizato K Seikagaku; 2005 Jul; 77(7):655-9. PubMed ID: 16114851 [No Abstract] [Full Text] [Related]
39. StAT signaling in cancer: insights into pathogenesis and treatment strategies. Frank DA Cancer Treat Res; 2003; 115():267-91. PubMed ID: 12613201 [No Abstract] [Full Text] [Related]
40. Molecular machines that control genes. Tjian R Sci Am; 1995 Feb; 272(2):54-61. PubMed ID: 7817187 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]